Original Article

You have full text access to this OnlineOpen article

Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy†

A single institutional experience with 359 cases

  1. Rohit Bhargava MD1,‡,*,
  2. Sushil Beriwal MD2,
  3. David J. Dabbs MD1,
  4. Umut Ozbek MS3,
  5. Atilla Soran MD4,
  6. Ronald R. Johnson MD4,
  7. Adam M. Brufsky MD5,
  8. Barry C. Lembersky MD5,
  9. Gretchen M. Ahrendt MD4

Article first published online: 3 FEB 2010

DOI: 10.1002/cncr.24876

Issue

Cancer

Cancer

Volume 116, Issue 6, pages 1431–1439, 15 March 2010

Additional Information

How to Cite

Bhargava, R., Beriwal, S., Dabbs, D. J., Ozbek, U., Soran, A., Johnson, R. R., Brufsky, A. M., Lembersky, B. C. and Ahrendt, G. M. (2010), Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy. Cancer, 116: 1431–1439. doi: 10.1002/cncr.24876

Author Information

  1. 1

    Department of Pathology, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania

  2. 2

    Department of Radiation Oncology, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania

  3. 3

    Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania

  4. 4

    Department of Surgery, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania

  5. 5

    Department of Medical Oncology, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania

  1. ‡

    Fax: (412) 641-1675

*Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, 300 Halket Street, Pittsburgh, PA 15213

  1. †

    We thank Louise Mazur and Karen Baurle for clerical assistance.

Publication History

  1. Issue published online: 3 MAR 2010
  2. Article first published online: 3 FEB 2010
  3. Manuscript Accepted: 10 JUL 2009
  4. Manuscript Revised: 17 JUN 2009
  5. Manuscript Received: 1 APR 2009
Corrected by:

Erratum: Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy

Vol. 117, Issue 10, 2238, Article first published online: 10 NOV 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (191K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    O. Humbert, A. Berriolo-Riedinger, J. M. Riedinger, B. Coudert, L. Arnould, A. Cochet, C. Loustalot, P. Fumoleau, F. Brunotte, Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes, Annals of Oncology, 2012,

    CrossRef

  2. 2
    Aida Kuzucan, Jeon-Hor Chen, Shadfar Bahri, Rita S. Mehta, Philip M. Carpenter, Peter T. Fwu, Hon J. Yu, David J.B. Hsiang, Karen T. Lane, John A. Butler, Stephen A. Feig, Min-Ying Su, Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy is Associated With Molecular Biomarker Profile, Clinical Breast Cancer, 2012, 12, 2, 110

    CrossRef

  3. 3
    Bohuslav Melichar, Helena Hornychová, Hana Kalábová, Hana Bašová, Jindřiška Mergancová, Hana Urminská, Pavel Jandík, Vladimír Červinka, Jan Laco, Aleš Ryška, Increased efficacy of a dose-dense regimen of neoadjuvant chemotherapy in breast carcinoma: a retrospective analysis, Medical Oncology, 2012,

    CrossRef

  4. 4
    Victoria C. Hodgkinson, Vijay Agarwal, Dalia ELFadl, John N. Fox, Penelope L. McManus, Tapan K. Mahapatra, Peter J. Kneeshaw, Philip J. Drew, Michael J. Lind, Lynn Cawkwell, Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer, Journal of Proteomics, 2012, 75, 9, 2745

    CrossRef

  5. 5
    Victoria C. Hodgkinson, Dalia ELFadl, Vijay Agarwal, Veerabhadram Garimella, Charlotte Russell, Ervine D. Long, John N. Fox, Penelope L. McManus, Tapan K. Mahapatra, Peter J. Kneeshaw, Philip J. Drew, Michael J. Lind, Lynn Cawkwell, Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: A possible role for 14-3-3 theta/tau and tBID?, Journal of Proteomics, 2012, 75, 4, 1276

    CrossRef

  6. 6
    Rohit Bhargava, Breast Pathology, 2012,

    CrossRef

  7. 7
    Rohit Bhargava, Breast Pathology, 2012,

    CrossRef

  8. 8
    Philippe L. Bedard, Fatima Cardoso, Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?, Nature Reviews Clinical Oncology, 2011, 8, 5, 272

    CrossRef

  9. 9
    Peter A Fasching, Katharina Heusinger, Lothar Haeberle, Melitta Niklos, Alexander Hein, Christian M Bayer, Claudia Rauh, Ruediger Schulz-Wendtland, Mayada R Bani, Michael Schrauder, Laura Kahmann, Michael P Lux, Johanna D Strehl, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, David L Wachter, Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment, BMC Cancer, 2011, 11, 1, 486

    CrossRef

  10. 10
    Luc Ceugnart, Bruno Coudert, Florence Dalenc, Jean-Marc Guinebretiere, Philippe Rouanet, Alain Toledano, Les traitements néoadjuvants (hors cancer du sein inflammatoire), Oncologie, 2011, 13, 10-11, 658

    CrossRef

  11. 11
    Ben Tran, Philippe L Bedard, Luminal-B breast cancer and novel therapeutic targets, Breast Cancer Research, 2011, 13, 6, 221

    CrossRef

  12. 12
    John A. Vargo, Sushil Beriwal, Gretchen M. Ahrendt, Atilla Soran, Ronald R. Johnson, Kandace McGuire, Rohit Bhargava, Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer, Oncology, 2011, 80, 5-6, 341

    CrossRef

  13. 13
    Kandace P. McGuire, Jorge Toro-Burguete, Hang Dang, Jessica Young, Atilla Soran, Margarita Zuley, Rohit Bhargava, Marguerite Bonaventura, Ronald Johnson, Gretchen Ahrendt, MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?, Annals of Surgical Oncology, 2011, 18, 11, 3149

    CrossRef

  14. 14
    Milvia Zambetti, Mauro Mansutti, Patricia Gomez, Ana Lluch, Christian Dittrich, Claudio Zamagni, Eva Ciruelos, Lorenzo Pavesi, Vladimir Semiglazov, Elena Benedictis, Fernando Gaion, Mario Bari, Paolo Morandi, Pinuccia Valagussa, Gianni Luca, Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II), Breast Cancer Research and Treatment, 2011, 132, 3, 843

    CrossRef

  15. 15
    Elaina S. R. Collie-Duguid, Kathleen Sweeney, Keith N. Stewart, Iain D. Miller, Elizabeth Smyth, Steven D. Heys, SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy, Breast Cancer Research and Treatment, 2011, 132, 3, 807

    CrossRef

  16. 16
    G Kristiansen, M Rose, C Geisler, F R Fritzsche, J Gerhardt, C Lüke, A-M Ladhoff, R Knüchel, M Dietel, H Moch, Z Varga, J-P Theurillat, T A Gorr, E Dahl, Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype, British Journal of Cancer, 2010, 102, 12, 1736

    CrossRef

  17. 17
    Seung Il Kim, Joohyuk Sohn, Ja Seung Koo, Se Ho Park, Hyung Seok Park, Byeong Woo Park, Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer, Oncology, 2010, 79, 5-6, 324

    CrossRef

  18. 18
    Rohit Bhargava, David J Dabbs, Sushil Beriwal, Isil A Yildiz, Preeti Badve, Atilla Soran, Ronald R Johnson, Adam M Brufsky, Barry C Lembersky, Kandace P McGuire, Gretchen M Ahrendt, Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer, Modern Pathology, 2010, 24, 3, 367

    CrossRef

  19. 19
    Hatem A Azim Jr, Martine J Piccart, Simultaneous targeting of estrogen receptor and HER2 in breast cancer, Expert Review of Anticancer Therapy, 2010, 10, 8, 1255

    CrossRef

  20. 20
    Sunati Sahoo, David J. Dabbs, Rohit Bhargava, Breast Pathology, 2008,

    CrossRef

View Full Article (HTML) Get PDF (191K)